Chemical Industries (Far East) Limited (SGX: C05)
Singapore
· Delayed Price · Currency is SGD 0.495
0.00 (0.00%)
Sep 11, 2024, 9:00 AM SGT
C05 Income Statement
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 72.58 | 72.58 | 100.03 | 85 | 63 | 62.22 | Upgrade
|
| Revenue Growth (YoY) | -27.44% | -27.44% | 17.69% | 34.92% | 1.26% | -9.60% | Upgrade
|
| Cost of Revenue | 66.87 | 66.87 | 93.11 | 62.93 | 43.69 | 46.59 | Upgrade
|
| Gross Profit | 5.71 | 5.71 | 6.93 | 22.07 | 19.31 | 15.63 | Upgrade
|
| Selling, General & Admin | 11.35 | 11.35 | 12.02 | 14.26 | 11.92 | 11.11 | Upgrade
|
| Other Operating Expenses | -1.82 | -1.82 | -2.35 | -1.32 | -1.23 | -0.35 | Upgrade
|
| Operating Expenses | 9.53 | 9.53 | 9.67 | 12.94 | 10.69 | 10.76 | Upgrade
|
| Operating Income | -3.82 | -3.82 | -2.74 | 9.13 | 8.62 | 4.86 | Upgrade
|
| Interest Expense | -0.09 | -0.09 | -0.07 | -0.15 | -0.18 | -0.2 | Upgrade
|
| Interest & Investment Income | 0.61 | 0.61 | 0.42 | 0.16 | 0.22 | 0.38 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.03 | -1.03 | -0.29 | 0.01 | -0.7 | 0.8 | Upgrade
|
| EBT Excluding Unusual Items | -4.32 | -4.32 | -2.67 | 9.15 | 7.97 | 5.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0 | -0 | -0.06 | 0.12 | 0.22 | -0.18 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.02 | -0.02 | 0 | - | -0.05 | 0.01 | Upgrade
|
| Asset Writedown | 9.8 | 9.8 | 6.4 | -3.86 | -2.53 | -1.2 | Upgrade
|
| Other Unusual Items | 0.21 | 0.21 | 0.39 | 0.41 | 1.24 | - | Upgrade
|
| Pretax Income | 5.67 | 5.67 | 4.07 | 5.81 | 6.84 | 4.47 | Upgrade
|
| Income Tax Expense | 0.52 | 0.52 | 0.51 | -0.99 | 1.27 | 1.11 | Upgrade
|
| Net Income | 5.15 | 5.15 | 3.55 | 6.8 | 5.57 | 3.36 | Upgrade
|
| Net Income to Common | 5.15 | 5.15 | 3.55 | 6.8 | 5.57 | 3.36 | Upgrade
|
| Net Income Growth | 44.82% | 44.82% | -47.74% | 22.08% | 65.97% | -68.60% | Upgrade
|
| Shares Outstanding (Basic) | 76 | 76 | 76 | 76 | 76 | 76 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 76 | 76 | 76 | 76 | 76 | Upgrade
|
| EPS (Basic) | 0.07 | 0.07 | 0.05 | 0.09 | 0.07 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.07 | 0.07 | 0.05 | 0.09 | 0.07 | 0.04 | Upgrade
|
| EPS Growth | 44.82% | 44.82% | -47.74% | 22.08% | 65.97% | -68.60% | Upgrade
|
| Free Cash Flow | -5.91 | -5.91 | -11.88 | 5.35 | 12 | 1.41 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.08 | -0.16 | 0.07 | 0.16 | 0.02 | Upgrade
|
| Dividend Per Share | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | Upgrade
|
| Gross Margin | 7.87% | 7.87% | 6.93% | 25.97% | 30.65% | 25.12% | Upgrade
|
| Operating Margin | -5.26% | -5.26% | -2.74% | 10.74% | 13.69% | 7.81% | Upgrade
|
| Profit Margin | 7.09% | 7.09% | 3.55% | 8.00% | 8.84% | 5.39% | Upgrade
|
| Free Cash Flow Margin | -8.15% | -8.15% | -11.88% | 6.30% | 19.04% | 2.26% | Upgrade
|
| EBITDA | 2.15 | 2.15 | 2.04 | 14.23 | 14.08 | 9.6 | Upgrade
|
| EBITDA Margin | 2.97% | 2.97% | 2.04% | 16.74% | 22.35% | 15.43% | Upgrade
|
| D&A For EBITDA | 5.97 | 5.97 | 4.78 | 5.1 | 5.46 | 4.74 | Upgrade
|
| EBIT | -3.82 | -3.82 | -2.74 | 9.13 | 8.62 | 4.86 | Upgrade
|
| EBIT Margin | -5.26% | -5.26% | -2.74% | 10.74% | 13.69% | 7.81% | Upgrade
|
| Effective Tax Rate | 9.14% | 9.14% | 12.59% | - | 18.61% | 24.92% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.